Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 272Terminated 79Unknown 37Active not recruiting 19Recruiting 17Withdrawn 9Not yet recruiting 3Approved for marketing 2Suspended 1Available 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Renal Cell 2Kidney Neoplasms 1

Interventions

Cisplatin 122Carboplatin 121Drug Therapy 118Bevacizumab 105Capecitabine 99Oxaliplatin 97Radiotherapy 95Paclitaxel 88Gemcitabine 88tislelizumab 87Cyclophosphamide 86Specimen Handling 80pembrolizumab 76toripalimab 67Magnetic Resonance Spectroscopy 65Fluorouracil 62sintilimab 59Injections 57Surgical Procedures, Operative 56Docetaxel 54anlotinib 51130-nm albumin-bound paclitaxel 48Immune Checkpoint Inhibitors 47fludarabine 46Standard of Care 45Pemetrexed 43Blood Specimen Collection 43Biopsy 43venetoclax 41lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Sunitinib × Clear all
NCT07165418 2025-09-10

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Peking University Cancer Hospital & Institute

Phase 3 Not yet recruiting
116 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT06032728 2023-09-13

Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

First Affiliated Hospital, Sun Yat-Sen University

Phase NA Not yet recruiting
488 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02688491 2016-02-25

A CpG-methylation-based Assay for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant Treatment

First Affiliated Hospital, Sun Yat-Sen University

Phase NA Not yet recruiting
300 enrolled
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡